Baxter International Inc. (NYSE:BAX), a global medtech leader, today reported results for the fourth quarter and full year ended Dec. 31, 2024, and provided its financial guidance for first-quarter ...

Strong Cost Discipline Leads to All-In Sustaining Costs Beating the Low End of Guidance and Delivering Another Strong Quarter of Free Cash Flow (All amounts are in U.S. dollars unless otherwise ...

LendingClub reported solid 4Q24 earnings, but guidance came in below expectations, causing the stock to sell off after ...

Ineffective committees fail to address needs of sick teachers in South Korea Struggling committees neglect vital concerns of ...

Aristotle Atlantic’s Large Cap Growth Composite posted a total return of 6.29% gross of fees, underperforming the 7.07% ...

This release should be read with the Company’s Financial Statements and Management Discussion & Analysis ('MD&A'), available at ...

In Sustaining Costs Beating the Low End of Guidance and Delivering Another Strong Quarter of Free Cash Flow (All amounts are in U.S. dollars un ...

Preparations for pivotal-stage readiness of vididencel in AML on trackThe hard work of the Mendus team to advance the company's lead product vididencel in acute myeloid leukemia (AML) continued to pay ...

John Streppa; Investor Relations; Amplitude Inc. Spenser Skates; Chairperson of the Board, Chief Executive Officer, Co-Founder; Amplitude Inc. Andrew Casey; Chief Fi ...

Highlights for the Three Months and Year Ended December 31, 2024: ...

Brumley: To me, a school is ordained to teach academic content. It's not established to be the parent or the nurse or the ...

Welcome to Amplitude's fourth quarter and full year 2024 earnings call. I'm John Streppa, head of investor relations. Joining ...